Tag: Prescription Drugs
AHA: Polypill, With or Without Aspirin, Reduces Cardiovascular Events
Significant reductions seen in primary outcome for use of polypill and polypill plus aspirin combination
Triplet Therapy Slows Refractory Multiple Myeloma
Progression-free survival longer with once-weekly selinexor-containing regimen versus standard bortezomib and dexamethasone
Fluvoxamine Linked to Reduction in Clinical Deterioration in COVID-19
Findings seen among adult outpatients with SARS-CoV-2 with oxygen saturation of 92 percent or greater
Nebulized Interferon Beta-1a Promising for COVID-19
Adults hospitalized for COVID-19 receiving SNG001 versus placebo more likely to show clinical improvement
ACR Previews New Pharmacotherapy Guidelines for RA
The 2020 Guideline for the Management of Rheumatoid Arthritis updates guidance on drug treatments
ACR: Warfarin Tied to Increased Risk for Knee, Hip Replacement in OA
Among adults with atrial fibrillation, warfarin use linked to increased odds of knee, hip replacement versus direct oral anticoagulants
AHA: Black Patients Less Likely to Receive Indicated BP Treatment Intensification
This accounts for about a quarter of the total effect on blood pressure control
Antipsychotic Use Declined in Young Children From 2009 to 2017
While there was a shift toward evidence-based indications, majority of use remains off-label
ACR: Incidence of COVID-19 Low in Patients With Rheumatic Disease
73 percent of those with SARS-CoV-2 infection not hospitalized; 11 percent of those hospitalized required ICU admission
AHA: Mavacamten May Treat Hypertrophic Cardiomyopathy
Improvements in cardiac structure, function seen at 30 weeks of treatment with mavacamten versus placebo
